S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
OTCMKTS:INPOY

InPost (INPOY) Stock Price, News & Analysis

$8.06
-0.11 (-1.35%)
(As of 05:38 PM ET)
Today's Range
$7.80
$8.06
50-Day Range
$7.22
$8.50
52-Week Range
$4.62
$8.50
Volume
1,937 shs
Average Volume
1,422 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
INPOY stock logo

About InPost Stock (OTCMKTS:INPOY)

InPost S.A., together with its subsidiaries, operates as an out-of-home e-commerce enablement platform providing parcel locker services in Europe. It operates through four segments: APM (Automated Parcel Machines), To-Door, Mondial Relay, and International Other. The APM segment focuses on the delivery of parcels to APM. The To-Door segment delivers parcels using door-to-door couriers. The Mondial Relay segment delivers parcels to APM; and operates pick-up drop-off (PUDO) points in France, Spain, Belgium, the Netherlands, Luxembourg, and Portugal. The International Other segment delivers parcels to APM and PUDO points in the United Kingdom and Italy. The company also provides fulfilment services; marketing and IT services; InPost Pay services; and platform for fast-moving consumer goods products through InPost Fresh app. InPost S.A. was founded in 1999 and is headquartered in Luxembourg, Luxembourg.

INPOY Stock Price History

INPOY Stock News Headlines

InPost (OTCMKTS:INPOY) Trading Up 2%
U.K. Producer Price Index (PPI) Input MoM
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Inpost SA Ordinary Shares INPST
InPost price target raised by EUR 0.20 at Barclays
Input/output devices
INPOY InPost S.A.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
InPost S.A. (INPOY)
Inpost Earnings, Revenue Beat in Q3
InPost S.A. ADR
See More Headlines
Receive INPOY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InPost and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Specialty Business Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:INPOY
CIK
N/A
Phone
N/A
Fax
N/A
Employees
6,950
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Rafal Brzoska (Age 47)
    President of Management Board & CEO
    Comp: $7.59M
  • Mr. Michael Rouse (Age 51)
    Vice President of Management Board & CEO of International
    Comp: $5.96M
  • Mr. Francisco Javier van Engelen Sousa (Age 56)
    CFO & Vice President of Board of Management
  • Ms. Arleta Adamus
    Compliance Officer
  • Ms. Izabela Karolczyk -Szafranska
    Chief Marketing & ESG Officer

INPOY Stock Analysis - Frequently Asked Questions

Should I buy or sell InPost stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for InPost in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" INPOY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INPOY, but not buy additional shares or sell existing shares.
View INPOY analyst ratings
or view top-rated stocks.

How have INPOY shares performed in 2024?

InPost's stock was trading at $6.7922 at the start of the year. Since then, INPOY shares have increased by 20.3% and is now trading at $8.17.
View the best growth stocks for 2024 here
.

Are investors shorting InPost?

InPost saw a increase in short interest in March. As of March 15th, there was short interest totaling 1,000 shares, an increase of 400.0% from the February 29th total of 200 shares. Based on an average daily trading volume, of 800 shares, the days-to-cover ratio is presently 1.3 days.
View InPost's Short Interest
.

How do I buy shares of InPost?

Shares of INPOY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:INPOY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners